Compare Merck & Company (6MK) vs. Competitors

70 Followers

Comparison Results

6MK

Merck & Company

€131.98

€316.98B

114.52

68.21%

14 Buy

6 Hold

0 Sell

Moderate Buy

Bristol-Myers Squibb

$64.72

$124.91B

13.47

33.72%

8 Buy

12 Hold

1 Sell

Moderate Buy

Johnson & Johnson

$273.14

$617.01B

29.60

37.67%

14 Buy

4 Hold

0 Sell

Strong Buy

Novartis

$159.98

$256.80B

21.30

7.66%

2 Buy

3 Hold

1 Sell

Hold

Pfizer

$28.57

$158.45B

36.73

2.66%

7 Buy

14 Hold

1 Sell

Moderate Buy

AbbVie

$265.79

$464.43B

74.04

11.10%

19 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs ABBV

xxxxxxxxxxxxx

Performance Comparison

DE:6MK

Merck & Company

127.50

53.46

72.20%

BMY

Bristol-Myers Squibb

61.15

17.93

41.50%

JNJ

Johnson & Johnson

256.03

72.02

39.14%

NVS

Novartis

141.00

11.29

8.70%

PFE

Pfizer

27.80

3.10

12.56%

ABBV

AbbVie

262.82

39.56

17.72%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >